Nicholas G Bacopoulos - Net Worth and Insider Trading
Nicholas G Bacopoulos Net Worth
The estimated net worth of Nicholas G Bacopoulos is at least $0 dollars as of 2024-11-13. Nicholas G Bacopoulos is the Director of Cyclacel Pharmaceuticals Inc and owns about 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) stock worth over $0. Details can be seen in Nicholas G Bacopoulos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nicholas G Bacopoulos has not made any transactions after 2008-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nicholas G Bacopoulos
Nicholas G Bacopoulos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nicholas G Bacopoulos owns 1 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) .
Click here to see the complete history of Nicholas G Bacopoulos’s form 4 insider trades.
Insider Ownership Summary of Nicholas G Bacopoulos
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2012-05-23 | director |
Nicholas G Bacopoulos Latest Holdings Summary
Nicholas G Bacopoulos currently owns a total of 1 stock. Nicholas G Bacopoulos owns 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) as of September 4, 2008, with a value of $0.
Latest Holdings of Nicholas G Bacopoulos
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2008-09-04 | 0 | 0.38 | 0 |
Holding Weightings of Nicholas G Bacopoulos
Nicholas G Bacopoulos Form 4 Trading Tracker
According to the SEC Form 4 filings, Nicholas G Bacopoulos has made a total of 0 transactions in Cyclacel Pharmaceuticals Inc (CYCC) over the past 5 years. The most-recent trade in Cyclacel Pharmaceuticals Inc is the sale of 0 shares on September 4, 2008, which brought Nicholas G Bacopoulos around $0.
Insider Trading History of Nicholas G Bacopoulos
- 1
Nicholas G Bacopoulos Trading Performance
Nicholas G Bacopoulos Ownership Network
Ownership Network List of Nicholas G Bacopoulos
Ownership Network Relation of Nicholas G Bacopoulos
Nicholas G Bacopoulos Owned Company Details
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
Nicholas G Bacopoulos is the director of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, Nicholas G Bacopoulos made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
Nicholas G Bacopoulos Mailing Address
Above is the net worth, insider trading, and ownership report for Nicholas G Bacopoulos. You might contact Nicholas G Bacopoulos via mailing address: C/o Cyclacel Pharmaceuticals, Inc., 200 Connelll Drive, Suite 1500, Berkeley Heights Nj 07922.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
